Erin Pennock Foff, Chief Medical Officer at MapLight Therapeutics, sold MPLT on Jul 17, 2026

Data as of Oct 16

▼ SELL$139K3,656 shares at $37.90Erin Pennock Foff Chief Medical OfficerMPLT MapLight Therapeutics, Inc.

Watch MPLT

Traded: Jul 17, 2026
Disclosed: Jul 17, 2026
Filed: The same day

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

MPLTSimilar stocks (XLV — its sector index fund), rebased to MPLT's price on the disclosure day

MPLT since disclosure

−79.7%

after the sale

Similar stocks (XLV) since disclosure

+9.7%

XLV — its sector index fund

Change in closing price from Jul 17, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

▼ SELLErin Pennock Foff Chief Medical OfficerMPLT MapLight Therapeutics, Inc.$721disclosed Jul 17 · filed 1 day after the trade
▼ SELLErin Pennock Foff Chief Medical OfficerMPLT MapLight Therapeutics, Inc.$334Kdisclosed Jul 17 · filed 1 day after the trade
▼ SELLErin Pennock Foff Chief Medical OfficerMPLT MapLight Therapeutics, Inc.$219Kdisclosed Jul 17 · filed 1 day after the trade
▼ SELLErin Pennock Foff Chief Medical OfficerMPLT MapLight Therapeutics, Inc.$332Kdisclosed Jul 17 · filed 2 days after the trade
▼ SELLErin Pennock Foff Chief Medical OfficerMPLT MapLight Therapeutics, Inc.$291Kdisclosed Jul 17 · filed 2 days after the trade
▼ SELLErin Pennock Foff Chief Medical OfficerMPLT MapLight Therapeutics, Inc.$161Kdisclosed Jul 17 · filed 2 days after the trade
▼ SELLErin Pennock Foff Chief Medical OfficerMPLT MapLight Therapeutics, Inc.$676disclosed Jul 17 · filed 2 days after the trade
▼ SELLErin Pennock Foff Chief Medical OfficerMPLT MapLight Therapeutics, Inc.$259Kdisclosed Jul 17 · filed 2 days after the trade

See every trade on MPLT →